First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Debinski, Waldemar
Item TypeName
Academic Article IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.
Academic Article Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2.
Academic Article Reoxygenation of hypoxic glioblastoma multiforme cells potentiates the killing effect of an interleukin-13-based cytotoxin.
Academic Article Alanine-scanning mutagenesis of alpha-helix D segment of interleukin-13 reveals new functionally important residues of the cytokine.
Academic Article Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma.
Academic Article Polymorphisms associated with asthma are inversely related to glioblastoma multiforme.
Academic Article An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk.
Academic Article Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy.
Academic Article Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2.
Academic Article Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.
Academic Article An interleukin 13 receptor a 2-specific peptide homes to human Glioblastoma multiforme xenografts.
Academic Article Toward intracellular targeted delivery of cancer therapeutics: progress and clinical outlook for brain tumor therapy.
Academic Article A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Ra2 tumor-restricted biomarker.
Concept Interleukin-13 Receptor alpha1 Subunit
Concept Interleukin-13
Concept Receptors, Interleukin-13
Concept Interleukin-13 Receptor alpha2 Subunit
Academic Article Engineered herpes simplex virus 1 is dependent on IL13Ralpha 2 receptor for cell entry and independent of glycoprotein D receptor interaction.
Academic Article New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors.
Grant High-Grade Astrocytoma-Specific Molecular Targeting
Grant Molecular Combinatorial Therapy of Glioblastoma Multiforme
Grant Molecular Requirements for Recombinant Cytotoxins Efficacy
Academic Article IL13RA2 targeted alpha particle therapy against glioblastomas.
Search Criteria
  • Interleukin 13